Sørensen Hans Peter, Sperling-Petersen Hans Uffe, Mortensen Kim Kusk
Laboratory of BioDesign, Department of Molecular Biology, Aarhus University, Gustav Wieds Vej 10 C, DK-8000 Aarhus C, Denmark.
Protein Expr Purif. 2003 Dec;32(2):252-9. doi: 10.1016/j.pep.2003.07.001.
Recombinant streptavidin is extremely difficult to express at high levels in the cytoplasm of Escherichia coli without the formation of inclusion bodies. Fusing a solubility enhancing partner to an aggregation prone protein is a widely used tool to circumvent inclusion body formation. Here, we use streptavidin as a target protein to test the properties of N-terminal fragments of translation initiation factor IF2 from E. coli as a solubility partner. Domain I (residue 1-158) of IF2 is superior to the well-established solubility partners maltose-binding protein (MBP) and NusA for soluble expression of active streptavidin. The number of active streptavidin molecules isolated by chromatography is increased threefold when domain I is used as solubility partner as compared to MBP or NusA. The relatively small size, high expressivity, and extreme solubility make domain I of IF2 an ideal partner for streptavidin and may also prevent other recombinant proteins such as ScFv antibodies from being expressed as insoluble aggregates in the cytoplasm of E. coli.
重组抗生物素蛋白极难在大肠杆菌细胞质中高水平表达而不形成包涵体。将一个增强溶解性的伴侣与易于聚集的蛋白融合是一种广泛使用的避免形成包涵体的方法。在这里,我们以抗生物素蛋白作为靶蛋白,来测试大肠杆菌翻译起始因子IF2的N端片段作为溶解性伴侣的特性。IF2的结构域I(第1至158位氨基酸残基)在活性抗生物素蛋白的可溶性表达方面优于成熟的溶解性伴侣麦芽糖结合蛋白(MBP)和NusA。与MBP或NusA相比,当使用结构域I作为溶解性伴侣时,通过色谱法分离得到的活性抗生物素蛋白分子数量增加了两倍。IF2结构域I相对较小的尺寸、高表达性和极高的溶解性使其成为抗生物素蛋白的理想伴侣,也可能防止其他重组蛋白如单链抗体片段(ScFv)抗体在大肠杆菌细胞质中以不溶性聚集体的形式表达。